Regulatory Affairs Professionals Society· @RAPSorg · X·· 25 天前精选AI 评分50
AI 导读
多家大型制药公司呼吁FDA在药品和生物制品容器密封系统检测指南中采用更灵活、基于风险的方法,尤其是在使用成熟材料和技术时。相关诉求通过RAPS发布的链接指向更详细内容。
推荐理由
原文呈现药企对FDA容器密封系统检测指南的诉求,读者可了解行业对风险导向监管的具体主张。
正文
Major pharmaceutical companies are urging the FDA to adopt a more flexible, risk-based approach in its guidance on testing container-closure systems for drugs and biological products, especially when established materials and technologies are used.
https://hubs.la/Q04C7mhF0
来源:Regulatory Affairs Professionals Society · x.com